Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)

Xiamen Amoytop Biotech Revenue

Xiamen Amoytop Biotech had revenue of 837.27M CNY in the quarter ending June 30, 2025, with 29.91% growth. This brings the company's revenue in the last twelve months to 3.14B, up 31.49% year-over-year. In the year 2024, Xiamen Amoytop Biotech had annual revenue of 2.82B with 34.13% growth.

• Revenue (ttm): 3.14B
• Revenue Growth: +31.49%
• P/S Ratio: 10.59
• Revenue / Employee: 1.17M
• Employees: 2,423
• Market Cap: 33.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.82B	716.84M	34.13%
Dec 31, 2023	2.10B	573.42M	37.55%
Dec 31, 2022	1.53B	394.68M	34.86%
Dec 31, 2021	1.13B	338.29M	42.61%
Dec 31, 2020	793.93M	64.27M	8.81%